| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.3M | +71.0% |
| Cost of Revenue | $12.4M | +205.8% |
| Gross Profit | $20.9M | +35.6% |
| R&D Expense | $1.6M | -44.2% |
| SG&A Expense | $13.7M | +61.1% |
| Pre-tax Income | $1.7M | +88.3% |
| Income Tax | $395K | +80.9% |
| Net Income | $1.3M | +90.7% |
| EPS (Basic) | $0.02 | +100.0% |
| EPS (Diluted) | $0.02 | +100.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.7M | -2.3% |
| Accounts Receivable | $756K | -54.1% |
| Current Assets | $16.2M | +49.9% |
| Total Assets | $23.1M | +46.4% |
| Current Liabilities | $5.2M | +142.0% |
| Total Liabilities | $6.0M | +130.0% |
| Stockholders' Equity | $17.1M | +29.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.1M | +44.0% |
| Investing Cash Flow | -$3.1M | -273.6% |
| Financing Cash Flow | -$187K | -104.6% |